Co-Authors
This is a "connection" page, showing publications co-authored by Dominik Jarczak and Mahir Karakas.
Connection Strength
0.283
-
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101). Biomolecules. 2020 08 11; 10(8).
Score: 0.224
-
MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19. Biomarkers. 2021 Jul; 26(5):417-424.
Score: 0.059